Preliminary data indicate that phosphorylated C/EBPa is directly recruited into the promoter region of lncRNA UCA1 in HA-treated CD44v3high head and neck cancer cells, resulting in lncRNA UCA1 expression (Figure 4B–1). Here, CEBPA is linked to head and neck cancer.